SpineX Receives FDA Breakthrough Device Designation for SCiP SpineX’s Proprietary non-surgical Device SCiP Offers New Hope for children with Cerebral Palsy LOS ANGELES, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early stage medtech company...

SpineX Announces Successful First in Human Study Results of SCONE therapy to treat Urge Urinary Incontinence SpineX’s Proprietary non-surgical SCONE™ Device Offers New Hope millions of individuals suffering from overactive bladder LOS ANGELES, March 23, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early...

SpineX Launches to Develop Non-Invasive Neuromodulation Devices to Address a Range of Medical Conditions LOS ANGELES, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Dr. V. Reggie Edgerton, the leading researcher into the neural control of movement and neuromuscular plasticity, today announced the launch of SpineX,...